_256_384.png)
News | November 19, 2025
Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening
India presents one of the world’s largest untapped opportunities for neurovascular screening
India presents one of the world’s largest untapped opportunities for neurovascular screening
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
This is the first drug to receive a recommendation for this preventative indication in the European Union
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
OncoMate MSI Dx Analysis System is a PCR-based assay designed to evaluate MSI status in tumor tissue
FIBROSARC did not meet its primary PFS endpoint in the final analysi
Enabling a new era in minimally invasive obesity treatment across Europe
Subscribe To Our Newsletter & Stay Updated
